Early antithrombotic therapy for another highly lethal viral pneumonia pandemic

X Wu, M Xiang, H Jing, L Liu… - Clinical …, 2023 - clinicalmicrobiologyandinfection …
Viral respiratory infections have threatened humanity throughout history. Newly emerging
and re-emerging diseases have spread with unprecedented speed and scale, thus posing a …

Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases

J Wang, P Ho, H Nandurkar, HY Lim - Journal of Thrombosis and …, 2024 - Springer
Thromboembolic diseases including arterial and venous thrombosis are common causes of
morbidity and mortality globally. Thrombosis frequently recurs and can also complicate …

[HTML][HTML] Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A …

D Chober, B Aksak-Wąs, J Niścigorska-Olsen… - Biomedicines, 2022 - mdpi.com
Introduction: Thromboembolic events, including mainly pulmonary embolisms and ischemic
strokes, occur in up to one-third of COVID-19 patients. As efficacy of tocilizumab (TCZ) …

The everlasting challenge to identify deep vein thrombosis in both clinical practice and research

CA Behrendt, R Twerenbold… - European heart …, 2022 - academic.oup.com
This commentary refers to 'Multi-organ assessment in mainly non-hospitalized individuals
after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme'by EL …

[HTML][HTML] Hypercholesterolemia and COVID-19: statins for lowering the risk of venous thromboembolism

A Vuorio, R Lassila, PT Kovanen - Frontiers in cardiovascular …, 2021 - frontiersin.org
In this Opinion letter, we focus on the prevention of venous thromboembolism in
hypercholesterolemic patients suffering from COVID-19. We present the heterozygous form …

[HTML][HTML] Monitoring of pulmonary involvement in critically ill COVID-19 patients-should lung ultrasound be preferred over CT?

AWE Lieveld, MLA Heldeweg, J Schouwenburg… - The Ultrasound …, 2023 - Springer
Background It is unclear if relevant changes in pulmonary involvement in critically ill COVID-
19 patients can be reliably detected by the CT severity score (CTSS) and lung ultrasound …

[HTML][HTML] Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19

A Liontos, D Biros, R Matzaras, KH Tsarapatsani… - Diagnostics, 2023 - mdpi.com
Background: A link between inflammation and venous thromboembolism (VTE) in COVID-19
disease has been suggested pathophysiologically and clinically. The aim of this study was …

Persistent pulmonary disease after acute covid-19

E Fraser - bmj, 2021 - bmj.com
It has been over a year since the first patients were discharged from UK hospitals following
treatment for covid-19. Hospital admission was largely dictated by the requirement for …

[HTML][HTML] Bleeding and thrombotic complications in patients with severe COVID‐19: A prospective observational study

MA Helmy, LM Milad, A Hasanin, EA Elsayed… - Health Science …, 2022 - ncbi.nlm.nih.gov
2. METHODS This prospective observational study was conducted in a university hospital
after the institutional Ethics Committee approval (N‐124‐2021). Written informed consent …

Therapeutic Enoxaparin Dosing in Obesity

M Appay, S Kharadi, S Nanayakkara… - Annals of …, 2024 - journals.sagepub.com
Objective: This review aims to systematically summarize the available data on efficacy and
safety of therapeutic enoxaparin in obese patients and to identify gaps to guide future …